Business description: Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows:

- hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.;

- perfusion and clinical nutrition (39.1%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. ;

- other (1.7%).

Number of employees: 175,202

Sales by Activity: Fresenius SE & Co. KGaA

Fiscal Period: December20202021202220232024

Fresenius Helios

9.82B 10.89B 11.72B 12.32B 12.74B

Fresenius Kabi

6.98B 7.19B 7.85B 8.01B 8.41B

Corporate / Other

-444M -480M -483M -386M 680M

Fresenius Vamed

2.07B 2.3B 2.36B 2.36B -

Fresenius Medical Care

17.86B 17.62B 19.4B - -
See all business segments

Geographical breakdown of sales: Fresenius SE & Co. KGaA

Fiscal Period: December20202021202220232024

Europe

15.81B 16.89B 17.88B 16.15B 15.66B

North America

14.8B 14.36B 16.11B 2.74B 2.7B

Asia-Pacific

3.7B 3.94B 4.14B 1.64B 1.6B

Latin America

1.57B 1.83B 2.18B 1.42B 1.4B

Africa

392M 501M 534M 356M 156M
See all geographic segments

Executive Committee: Fresenius SE & Co. KGaA

Manager TitleAgeSince
Chief Executive Officer 56 2022-09-30
Director of Finance/CFO 45 2022-08-31
Compliance Officer 48 -
Corporate Secretary - -
Investor Relations Contact - 2014-12-31
See FRESENIUS SE & CO. KGAA governance

Composition of the Board of Directors: Fresenius SE & Co. KGaA

Director TitleAgeSince
Director/Board Member 70 2015-05-19
Director/Board Member 64 2016-05-12
Director/Board Member 51 2007-12-31
Director/Board Member 66 2018-08-31
Chairman 70 2021-05-20
Director/Board Member 52 2020-04-30
Director/Board Member 64 2022-02-08
Director/Board Member 63 2022-05-12
Composition of the Board of Directors

Shareholders: Fresenius SE & Co. KGaA

NameEquities%Valuation
Else Kröner-Fresenius-Stiftung
26.96 %
151,842,509 26.96 % 7 443 M €
Fidelity Management & Research Co. LLC
3.058 %
17,222,989 3.058 % 844 M €
Harris Associates LP
2.992 %
16,850,886 2.992 % 826 M €
Eleva Capital SAS
0.9516 %
5,359,955 0.9516 % 263 M €
AllianceBernstein Investments Taiwan Ltd.
0.5717 %
3,219,839 0.5717 % 158 M €
NameEquities%Valuation
BG Fund Management Luxembourg SA
-
4,165 - - €
NameEquities%Valuation
Yousif Capital Management LLC
0.001119 %
25,206 0.001119 % 308 900 €
RhumbLine Advisers LP
0.000329 %
7,421 0.000329 % 90 944 €
GAMMA Investing LLC
0.000012 %
264 0.000012 % 3 235 €
Brooklyn Investment Group LLC
0.000005 %
104 0.000005 % 1 275 €
List of FRESENIUS SE & CO. KGAA shareholders

Holdings: Fresenius SE & Co. KGaA

NameEquities%Valuation
83,780,382 28.55% 4,757,486,586 $

Company details: Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

Else-Kröner-Strasse 1

61352, Bad Homburg

+49 6172 6080

http://www.fresenius.de
address Fresenius SE & Co. KGaA(FRE)

Group companies: Fresenius SE & Co. KGaA

NameCategory and Sector
Pharmaceuticals: Major
Medical Specialties
Medical/Nursing Services
Fresenius-Kawasumi Co., Ltd.
Pharmaceuticals: Other
See all subsidiaries

Other Healthcare Facilities & Services

Change 5d. change 1-year change 3-years change Capi.($)
-1.14%-5.83%+46.12%+42.57% 27.27B
+1.18%+2.52%+10.63%+117.71% 90.66B
-0.37%+1.70%+9.56%-24.61% 84.55B
+0.67%-3.82%-19.40%+22.12% 22.39B
+0.75%+0.55%+26.58%+15.55% 21.88B
+0.46%+1.58%+30.94%+37.61% 20.07B
-0.87%-7.26%+27.55%-7.15% 15.76B
+0.07%+3.82%+21.87%+216.49% 15.57B
-0.62%-0.14%+34.62%+17.02% 14.18B
-2.24%-3.72%+28.45%+219.52% 13.3B
Average -0.20%-0.22%+21.69%+65.68% 32.56B
Weighted average by Cap. +0.11%+1.13%+16.71%+54.54%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
42.04EUR
Average target price
49.22EUR
Spread / Average Target
+17.08%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. FRE Stock
  4. Company Fresenius SE & Co. KGaA